Part 1 General approach to history and examination: nervous system; concious level and assessment; higher cerebal function; cranial nerve examination; upper limbs; trunk; lower limbs; posture and gait; the unconcious patient. Part 2 Investigation of the central and peripheral nervous system: skull X-ray; computerized tomography (CT) scanning; magnetic resonance imaging (MRI); ultrasound; digital subtraction angiography (DSA); radionuclide imaging; electroencephalography (EEG); intracranial pressure monitoring; invoked potentials - visual, auditory and somatosensory; lumbar puncture; electromyography/nerve conduction studies; neuro-otological tests. Part 3 Clinical presentation, anatomical concepts and diagnostic approach: headache; raised intracranial pressure; coma and impaired concious level; transient loss of conciousness; confusional states and delirium; epilepsy; disorders of sleep; higher cortical dysfunction; disorders of speech and language; dementias; impairment of vision; disorders of smell; pupillary disorders; diplopia - impaired ocular movement; disorders of gaze; facial pain and sensory loss; deafness, tinnitus and vertigo; disorders of the lower cranial nerves; cerebellar dysfunction; nystagmus; tremor; myoclonus; disorders of stance and gait; limb weakness; sensory impairment; pain; muscle pain; brain death. Part 4 Localized neurological disease and its management: intracranial - head injury, chronic subdural haematoma, cerebrovascular disease; intracranial tumours; intracranial abscess; movement disorders, extrapyramidal system; hydrocephalus; benign intracranial hypertension; developmental anomalies; stereotactic and psychosurgery; spinal cord and roots - spinal cord and root compression, disc prolapse and spondylosis, spinal trauma, vascular disease, spinal dysraphism; peripheral nerve and muscle - polyneuropathies; plexus syndromes and mononeuropathies; the autonomic nervous system; diseases of skeletal muscle; myasthenia gravis. Part 5 Multifocal neurological disease and its management; infections; demyelinating diseases; neurological complications of drugs and toxins; metabolic encephalopathies; nutritional disorders; non-metastatic manifestations of malignant disease; degenerative disorders; motor neuron disease; the neurocutaneous syndromes.
